Sysmex Stock

Sysmex EBIT

The EBIT of Sysmex (6869.T) as of Sep 6, 2026 is 90.35 B JPY. In the previous year, EBIT was 80.06 B JPY — a change of 12.86% (higher).

EBIT

90.35 BJPY

YoY

12.86%

Last updated:

In 2026, Sysmex's EBIT was 90.35 B JPY, a 12.86% increase from the 80.06 B JPY EBIT recorded in the previous year.

The Sysmex EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2024
80.06 B JPY
Jan 1, 2025
90.35 B JPY
Jan 1, 2026 (e)
61.71 B JPY
Jan 1, 2027 (e)
63.35 B JPY
Jan 1, 2028 (e)
75.82 B JPY
Jan 1, 2029 (e)
87.13 B JPY
Jan 1, 2030 (e)
105.05 B JPY
Jan 1, 2031 (e)
115.78 B JPY
The Sysmex EBIT history
YEAREBITYoY
est115.78 BJPY+10.22%
est105.05 BJPY+20.56%
est87.13 BJPY+14.92%
est75.82 BJPY+19.70%
est63.35 BJPY+2.65%
est61.71 BJPY-31.70%
90.35 BJPY+12.86%
80.06 BJPY+8.19%
73.99 BJPY+7.31%
68.95 BJPY+38.28%
49.86 BJPY-9.16%
54.89 BJPY-10.65%
61.43 BJPY+2.37%
60.01 BJPY+15.59%
51.92 BJPY-15.00%
61.08 BJPY+37.52%
44.41 BJPY+35.11%
32.87 BJPY+50.75%
21.80 BJPY+13.53%
19.21 BJPY+5.01%
18.29 BJPY+16.43%
15.71 BJPY+6.19%
14.79 BJPY-1.61%
15.04 BJPY+18.24%
12.72 BJPY+18.65%
10.72 BJPY
Access this data via the Eulerpool API

Sysmex Revenue

Sysmex Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
461.51 B JPY
80.06 B JPY
49.64 B JPY
Jan 1, 2025
508.64 B JPY
90.35 B JPY
53.67 B JPY
Jan 1, 2026 (e)
498.17 B JPY
61.71 B JPY
39.94 B JPY
Jan 1, 2027 (e)
545.91 B JPY
63.35 B JPY
42.13 B JPY
Jan 1, 2028 (e)
575.75 B JPY
75.82 B JPY
52.07 B JPY
Jan 1, 2029 (e)
607.91 B JPY
87.13 B JPY
61.07 B JPY
Jan 1, 2030 (e)
649.16 B JPY
105.05 B JPY
69.63 B JPY
Jan 1, 2031 (e)
690.04 B JPY
115.78 B JPY
76.96 B JPY

Sysmex Margins

Sysmex stock margins

The Sysmex margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sysmex. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sysmex.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
52.54 %
17.35 %
10.76 %
Jan 1, 2025
53.47 %
17.76 %
10.55 %
Jan 1, 2026 (e)
53.47 %
12.39 %
8.02 %
Jan 1, 2027 (e)
53.47 %
11.60 %
7.72 %
Jan 1, 2028 (e)
53.47 %
13.17 %
9.04 %
Jan 1, 2029 (e)
53.47 %
14.33 %
10.05 %
Jan 1, 2030 (e)
53.47 %
16.18 %
10.73 %
Jan 1, 2031 (e)
53.47 %
16.78 %
11.15 %

Sysmex Stock analysis

What does Sysmex do? Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Sysmex's EBIT

Sysmex's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Sysmex's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Sysmex's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Sysmex’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Sysmex stock

EBIT of Sysmex is 90.35 B JPY in 2026.

EBIT of Sysmex changed from 80.06 B JPY to 90.35 B JPY, representing a 12.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Sysmex since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Sysmex historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Sysmex

All Key Metrics — Sysmex